Amalgam (dentistry) on Mercury) general opinion on its safety is unlikely to change. These are some of the reasons why amalgam has remained a superior restorative material over resin-base composites. The New England Children's Amalgam Trial (NECAT), a randomized controlled trial, yielded results "consistent with previous reports suggesting that the longevity of amalgam is higher than that of resin-based compomer in primary teeth and composites in permanent teeth. Compomers were seven times as likely to require replacement and composites were seven times as likely to require repair. There are circumstances in which composite serves better than amalgam. For example, when a more
Dental amalgam controversy years. All available world-wide research indicates that amalgam is not harmful to health... No Government or reputable scientific, medical or dental body anywhere in the world accepts, on any published evidence, that dental amalgam is a hazard to health." The Irish Dental Association provides additional detail in a published patient information letter. France has publicly recognized the safety and effectiveness of amalgam restorations. A position paper on the Association Dentaire Française website states that amalgam restorations have proven to have no biological or toxic effect. They also mention that no serious pathological fact has ever been observed and no general